4//SEC Filing
Cole Jeffrey Scott 4
Accession 0001213900-24-029930
CIK 0001937993other
Filed
Apr 2, 8:00 PM ET
Accepted
Apr 3, 5:21 PM ET
Size
5.7 KB
Accession
0001213900-24-029930
Insider Transaction Report
Form 4
Cole Jeffrey Scott
Chief Operating Officer
Transactions
- Award
Stock Options
2024-04-02+150,000→ 150,000 totalExercise: $0.62From: 2025-04-01Exp: 2034-04-01→ Common Stock (150,000 underlying)
Footnotes (1)
- [F1]Consists of options to purchase 150,000 shares of common stock, which shall vest 1/4 on April 1, 2025 and thereafter pro rata on a monthly basis over three years, subject to the Reporting Person's continued service to the Issuer through each vesting date, having an exercise price equal to the fair market value of the Issuer's common stock on the effective date of the grant.
Documents
Issuer
Cadrenal Therapeutics, Inc.
CIK 0001937993
Entity typeother
Related Parties
1- filerCIK 0001751100
Filing Metadata
- Form type
- 4
- Filed
- Apr 2, 8:00 PM ET
- Accepted
- Apr 3, 5:21 PM ET
- Size
- 5.7 KB